Acute respiratory distress syndrome
KD Wick, LB Ware, MA Matthay - bmj, 2024 - bmj.com
The understanding of acute respiratory distress syndrome (ARDS) has evolved greatly since
it was first described in a 1967 case series, with several subsequent updates to the definition …
it was first described in a 1967 case series, with several subsequent updates to the definition …
Heart-lung crosstalk in acute respiratory distress syndrome
NN Rocha, PL Silva, D Battaglini… - Frontiers in Physiology, 2024 - frontiersin.org
Acute Respiratory Distress Syndrome (ARDS) is initiated by a primary insult that triggers a
cascade of pathological events, including damage to lung epithelial and endothelial cells …
cascade of pathological events, including damage to lung epithelial and endothelial cells …
[HTML][HTML] IL-18 and IL-18BP: A Unique Dyad in Health and Disease
D Novick - International Journal of Molecular Sciences, 2024 - mdpi.com
Interleukin-18 (IL-18) serves a dual function in the immune system, acting as a “double-
edged sword” cytokine. Depending on the microenvironment and timing, IL-18 can either …
edged sword” cytokine. Depending on the microenvironment and timing, IL-18 can either …
[HTML][HTML] Accuracy study of Angiotensin 1–7 composite index test to predict pulmonary fibrosis and guide treatment
N De Vos, M Bruyneel, A Roman, M Antoine… - Clinica chimica acta, 2025 - Elsevier
Background Pulmonary fibrosis can develop after acute respiratory distress syndrome
(ARDS). The hypothesis is we are able to measure phenotypes that lie at the origin of ARDS …
(ARDS). The hypothesis is we are able to measure phenotypes that lie at the origin of ARDS …
Identifying a hyperinflammatory subphenotype of ARDS associated with worse outcomes: may ferritin help?
LK Torres, II Siempos - Thorax, 2024 - thorax.bmj.com
Attributable mortality of acute respiratory distress syndrome (ARDS) is considerable. 1 2 Yet,
no survival benefit has been shown in randomised controlled trials (RCTs) of …
no survival benefit has been shown in randomised controlled trials (RCTs) of …
Preventing COVID-19 Sequelae with Theranostic Algorithm: Analytical and Clinical Performance of Angiotensin-(1-7) Composite Index Test for Guiding Therapeutic …
N De Vos, M Bruyneel, A Roman, M Antoine… - Available at SSRN … - papers.ssrn.com
Background: A theranostic algorithm links in vitro diagnostics to targeted therapy. The aim is
to diagnose severe COVID-19, and prevent sequelae like pulmonary fibrosis after acute …
to diagnose severe COVID-19, and prevent sequelae like pulmonary fibrosis after acute …